ELAN — Elanco Animal Health Incorporated
$22.52-0.75%
Last close: · regular session
After-hours $22.35 -0.75% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ELAN in the TickerWise workspace.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Company profile
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
- Exchange: NYSE
- Employees: 9,000
- Website: https://www.elanco.com
Latest SEC filings for ELAN
Latest ELAN news
- Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report? Read article
- Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.